When was Resilience founded?

Resilience was founded in 1995 and raised its 1st funding round 11 years after it was founded.

Where is Resilience located?

Resilience is headquartered in San Diego, United States.

How many employees does Resilience have?

As of Sep 30, 2026, the latest employee count at Resilience is 1299.

Is Resilience a funded company?

Resilience is a funded company, having raised a total of $1.99B across 11 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 24, 2006.

When was the latest funding round of Resilience?

Resilience's latest funding was a $***** Venture Debt round on Oct 29, 2025, with participation from 1 investor.

Where does Resilience rank among its competitors?

Resilience ranks 1st amongst 104 active competitors, of which 22 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was SpliSense, which secured $13M in Jun, 2026.

Who are the top competitors of Resilience?

Resilience's top competitors include Pluri, Oxford BioMedica and Mytos. Among them, SpliSense secured the most recent funding round in June, 2026.

Resilience - 2026 Company Profile, Team, Funding & Competitors

Resilience is a series D company based in San Diego (United States), founded in 1995 by Rahul Singhvi. It operates as a Provider of supply chain services for biopharma sector. Resilience has raised $1.99B in funding from investors like Kennet Partners, Arch Venture Partners and Mubadala. The company has 104 active competitors, including 22 funded and 16 that have exited. Its top competitors include companies like Pluri, Oxford BioMedica and Mytos.

Company Details

Website: resilience.com
Email ID: *****@resilience.com

Key Metrics

Founded Year

1995

Location

San Diego, United States

Stage

Series D

Total Funding

$1.99B in 11 rounds

Latest Funding Round

Venture Debt, Oct 29, 2025, $*****

Investors

Kennet Partners & 20 more

Ranked

1^st among 104 active competitors

Employee Count

1,299 as on Sep 30, 2026

Investment & Acquisitions

SwiftScale & 3 more

Similar Companies

McKesson & 444 more

View Resilience's full profile

Resilience has raised a total funding of $1.99B over 11 rounds. Its first funding round was on Apr 24, 2006. Its latest funding round was a Venture Debt round on Oct 29, 2025 for $*****. 1 investor participated in its latest round. Resilience has 21 institutional investors.

Here is the list of recent funding rounds of Resilience:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 29, 2025	9473835	Venture Debt	5310801	2807138	3784573	9659790
Oct 03, 2024	2765964	Grant (prize money)	3196291	2471230	9630357	1286452
Mar 24, 2023	2996443	Conventional Debt	3345704	3243497	7850522	Defense.gov & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Resilience's funding rounds and investors

The founders of Resilience is Rahul Singhvi.

Here are the details of Resilience's key team members:

Rahul Singhvi: Former Co-Founder of Resilience.
Contact Info: 1 email address

View details of Resilience's Founder profiles and Board Members

Resilience's employee count trend

Resilience has 1,299 employees as of Sep 26. Here is Resilience's employee count trend over the years:

Uncover Resilience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Resilience include Pluri, Oxford BioMedica and Mytos. Here is the list of Top 10 competitors of Resilience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Resilience 1995, San Diego (United States), Series D	Provider of supply chain services for biopharma sector	$1.99B	Mubadala, Applied Materials & 19 others	61/100
2nd	Pluri 2003, Haifa (Israel), Public	Developer of three-dimensional cell expansion platforms for various industries	-	Merchant Adventure Investment Advisors, Europa ... & 2 others	61/100
3rd	Oxford BioMedica 1995, Oxford (United Kingdom), Public	Manufacturer of viral vectors for cell and gene therapy products	-	Oberland Capital, Vitruvian Partners & 7 others	58/100
4th	Mytos 2016, London (United Kingdom), Series A	Provider of automated cell manufacturing for regenerative medicine applications	$19M	Buckley Ventures, Wing Venture Capital & 6 others	58/100
5th	Orgenesis 2008, Germantown (United States), Public	Developer of cell and gene therapies for multiple disorders	-	Kodiak Capital, Metalmark Capital & 4 others	55/100
6th	Genflow Biosciences 2020, Charleroi (Belgium), Public	CDMO focused on developing of gene therapies to reverse the aging processes	-	Wallonia, Longevitytech.fund & 1 others	49/100
7th	Porton Advanced Solutions 2018, Suzhou (China), Series B	Provider of cell & gene therapy, discovery research, analytical development, and testing services	$80M	HM Capital, Momentum Ventures & 6 others	49/100
8th	eXmoor 2004, Bristol (United Kingdom), Series A	Provider of cell & gene therapautic services for biopharmaceutical sector	$51.7M	MVM, Kineticos	47/100
9th	SpliSense 2016, Jerusalem (Israel), Series B	Limited information available	$41.5M	Cystic Fibrosis Foundation, Orbimed & 2 others	47/100
10th	Ubrigene 2015, Beijing (China), Series C	CDMO focused on providing services for cell therapy and AAV vector products	-	Goldstone Investment , Huagai Capital & 12 others	44/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Resilience's competitors? Click here to see the top ones

Resilience has made 2 investments in companies including Bit.bio and Garuda. Resilience has also acquired 2 companies including SwiftScale and Ology Bio.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Dec 02, 2021	Acquisition	SwiftScale	2019	San Francisco (United States)
Sep 30, 2021	Investments	Bit.bio	2016	Cambridge (United Kingdom)
Sep 23, 2021	Investments	Garuda	2021	Natick (United States)